KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $13.2 billion.

  • Amgen's Other Non-Current Assets rose 2733.31% to $13.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 billion, marking a year-over-year increase of 2733.31%. This contributed to the annual value of $9.9 billion for FY2024, which is 331.91% up from last year.
  • Per Amgen's latest filing, its Other Non-Current Assets stood at $13.2 billion for Q3 2025, which was up 2733.31% from $11.0 billion recorded in Q2 2025.
  • Over the past 5 years, Amgen's Other Non-Current Assets peaked at $13.2 billion during Q3 2025, and registered a low of $5.8 billion during Q1 2021.
  • Over the past 5 years, Amgen's median Other Non-Current Assets value was $7.6 billion (recorded in 2023), while the average stood at $8.1 billion.
  • Per our database at Business Quant, Amgen's Other Non-Current Assets crashed by 958.0% in 2022 and then soared by 6292.59% in 2023.
  • Over the past 5 years, Amgen's Other Non-Current Assets (Quarter) stood at $6.5 billion in 2021, then dropped by 9.58% to $5.9 billion in 2022, then skyrocketed by 62.93% to $9.6 billion in 2023, then increased by 3.32% to $9.9 billion in 2024, then soared by 33.14% to $13.2 billion in 2025.
  • Its Other Non-Current Assets stands at $13.2 billion for Q3 2025, versus $11.0 billion for Q2 2025 and $11.4 billion for Q1 2025.